112 related articles for article (PubMed ID: 34958370)
1. p62/SQSTM1 promotes mitophagy and activates the NRF2-mediated antioxidant and anti-inflammatory response restraining EBV-driven B lymphocyte proliferation.
Gilardini Montani MS; Tarquini G; Santarelli R; Gonnella R; Romeo MA; Benedetti R; Arena A; Faggioni A; Cirone M
Carcinogenesis; 2022 Apr; 43(3):277-287. PubMed ID: 34958370
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization.
Granato M; Gilardini Montani MS; Zompetta C; Santarelli R; Gonnella R; Romeo MA; D'Orazi G; Faggioni A; Cirone M
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31547402
[TBL] [Abstract][Full Text] [Related]
3. EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation.
Gilardini Montani MS; Santarelli R; Granato M; Gonnella R; Torrisi MR; Faggioni A; Cirone M
Autophagy; 2019 Apr; 15(4):652-667. PubMed ID: 30324853
[TBL] [Abstract][Full Text] [Related]
4. p62-mediated Selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress.
Wang L; Howell MEA; Sparks-Wallace A; Hawkins C; Nicksic CA; Kohne C; Hall KH; Moorman JP; Yao ZQ; Ning S
PLoS Pathog; 2019 Apr; 15(4):e1007541. PubMed ID: 31017975
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1.
Granato M; Gilardini Montani MS; Angiolillo C; D'Orazi G; Faggioni A; Cirone M
Viruses; 2018 Dec; 11(1):. PubMed ID: 30586869
[TBL] [Abstract][Full Text] [Related]
6. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1.
Hashimoto K; Simmons AN; Kajino-Sakamoto R; Tsuji Y; Ninomiya-Tsuji J
Antioxid Redox Signal; 2016 Dec; 25(17):953-964. PubMed ID: 27245349
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus deubiquitinase BPLF1 targets SQSTM1/p62 to inhibit selective autophagy.
Ylä-Anttila P; Gupta S; Masucci MG
Autophagy; 2021 Nov; 17(11):3461-3474. PubMed ID: 33509017
[TBL] [Abstract][Full Text] [Related]
8. The master antioxidant defense is activated during EBV latent infection.
Wang L; Howell MEA; Hensley CR; Ning K; Moorman JP; Yao ZQ; Ning S
J Virol; 2023 Nov; 97(11):e0095323. PubMed ID: 37877721
[TBL] [Abstract][Full Text] [Related]
9. HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles.
Medvedev R; Ploen D; Spengler C; Elgner F; Ren H; Bunten S; Hildt E
Free Radic Biol Med; 2017 Sep; 110():300-315. PubMed ID: 28673615
[TBL] [Abstract][Full Text] [Related]
10. p62 promotes proliferation, apoptosis‑resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis.
Jiang G; Liang X; Huang Y; Lan Z; Zhang Z; Su Z; Fang Z; Lai Y; Yao W; Liu T; Hu L; Wang F; Huang H; Liu L; Jiang X
Oncol Rep; 2020 May; 43(5):1547-1557. PubMed ID: 32323805
[TBL] [Abstract][Full Text] [Related]
11. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
12. 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity Against Oral Cancer Cells Through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.
Liu YC; Peng BR; Hsu KC; El-Shazly M; Shih SP; Lin TE; Kuo FW; Chou YC; Lin HY; Lu MC
Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32718084
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization.
Wang J; Nagy N; Masucci MG
Oncogene; 2020 Jan; 39(3):603-616. PubMed ID: 31511648
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
[TBL] [Abstract][Full Text] [Related]
15. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Saito T; Ichimura Y; Taguchi K; Suzuki T; Mizushima T; Takagi K; Hirose Y; Nagahashi M; Iso T; Fukutomi T; Ohishi M; Endo K; Uemura T; Nishito Y; Okuda S; Obata M; Kouno T; Imamura R; Tada Y; Obata R; Yasuda D; Takahashi K; Fujimura T; Pi J; Lee MS; Ueno T; Ohe T; Mashino T; Wakai T; Kojima H; Okabe T; Nagano T; Motohashi H; Waguri S; Soga T; Yamamoto M; Tanaka K; Komatsu M
Nat Commun; 2016 Jun; 7():12030. PubMed ID: 27345495
[TBL] [Abstract][Full Text] [Related]
16. Iron deficiency induces autophagy and activates Nrf2 signal through modulating p62/SQSTM.
Inoue H; Hanawa N; Katsumata SI; Katsumata-Tsuboi R; Takahashi N; Uehara M
Biomed Res; 2017; 38(6):343-350. PubMed ID: 29225212
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
Chen X; Kamranvar SA; Masucci MG
Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
[TBL] [Abstract][Full Text] [Related]
19. Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells.
Tsai TF; Chen PC; Lin YC; Chou KY; Chen HE; Ho CY; Lin JF; Hwang TI
Drug Des Devel Ther; 2020; 14():1209-1218. PubMed ID: 32273683
[TBL] [Abstract][Full Text] [Related]
20. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
